The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
ARDS - Acute lung injury
Publications
Merle P, Camus P, Abergel A, Pageaux GP, Masliah C, Bronowicki JP, Zarski JP, Pelletier G, Bouattour M, Farloux L, Dorval E, Verset G, Si-Ahmed SN, Doffoel M, Couzigou P, Taieb J, Vasseur B, Attali P
Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma.
ESMO open. 2017;2(4):e000238
Lipiodol embolism following transarterial chemoembolization: an atypical case.
Critical care medicine. 2014;42(6):e481-4
Chemoembolization of hepatocellular carcinoma with drug-eluting beads complicated by interstitial pneumonitis.
Seminars in interventional radiology. 2011;28(2):218-21
Acute lung injury following transcatheter hepatic arterial chemoembolization of doxorubicin-loaded LC beads in a patient with hepatocellular carcinoma.
Lung India : official organ of Indian Chest Society. 2012;29(2):169-72
Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer.
Journal of vascular and interventional radiology : JVIR. 2002;13(9 Pt 1):893-900
Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma.
Radiology. 1993;187(3):689-93